Target intelligence / Profile preview

Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1)

Target
UCHL1
Molecular classification
Enzyme, Deubiquitinase, Hydrolase
01

Overview

Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a deubiquitinating enzyme (DUB) that plays a critical role in the ubiquitin–proteasome system (UPS). It is highly expressed in neurons and cells of the diffuse neuroendocrine system. UCHL1 has hydrolase and ligase activities, maintaining cellular homeostasis by recycling ubiquitin molecules. Mutations or altered expression are implicated in neurodegenerative diseases like Parkinson’s and cancer. It localizes to nucleus, cytoplasm, endoplasmic reticulum, plasma membrane and mitochondria, showing its involvement in multiple aspects of intracellular protein regulation. By cleaving short peptide fragments from the C terminus of ubiquitinated substrates (~10 residues), it increases available monomeric ubiquitin pools necessary for ongoing proteasomal degradation cycles. It also stabilizes other important signaling molecules such as EGFR by preventing their degradation via deubiquitination pathways.

Other names
UCH-L1PGP9.5PARK5Neuron cytoplasmic protein 9.5HEL-117NDGOASPG79
02

Mechanism of action

Inhibition of deubiquitinase activity, modulation of ubiquitin levels

03

Biological functions

DeubiquitinationUbiquitin recyclingProtein homeostasisRegulation of proteasomal degradation
04

Disease associations

Parkinson's diseaseNeurodegenerative diseaseCancerTriple-negative breast cancer

Beyond the preview

Go deeper on Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call